An ultrasound transducer focuses sound energy to a point below the surface. At that point tissue reaches temperatures high enough to coagulate collagen - roughly 60 to 70 degrees Celsius - leaving tiny columns of denatured collagen. Everything between the transducer and that focal point is spared, including the outer skin.
Three focal depths are used, identified in the FDA paperwork by the transducer naming convention: about 1.5 mm, 3.0 mm and 4.5 mm. The deepest of the three is what makes the device distinctive, because 4.5 mm reaches the SMAS - the fibrous support layer beneath the face. Needle-based devices generally do not reach it.
Ultherapy is also the one device in this group with real-time imaging built in, so the operator can see the tissue plane before firing. The authorised purpose of that imaging is stated plainly: to confirm the transducer is properly coupled to the skin, and to confirm the depth of treatment so as to avoid bone.
Every part of that mechanism is about heating and contracting connective tissue. None of it is about removing fat.
Ultherapy began as a De Novo authorisation - DEN080006, granted 11 September 2009 - which created a whole new device category for focused ultrasound in aesthetics. The exact wording of that 2009 document could not be retrieved from the FDA archive, so the first wording that can be quoted from a primary source is the 2012 clearance.
The indications, as they stand, cover lifting the eyebrow, lifting lax tissue beneath the chin and on the neck, and improving lines and wrinkles of the decollete. A February 2025 clearance added skin laxity on the abdomen and the front and back of the arms, under a general statement that the system is intended to apply focused ultrasound energy to the body to achieve temporary changes in the physical appearance of the skin.
Fat, lipolysis, fat reduction and contouring appear nowhere. That matters for a practical reason: if a clinic tells you the treatment will slim your face or shrink a double chin, they are describing something the device has never been authorised to do.
One more piece of context. A clearance or an authorisation is a marketing permission, not a certificate that a treatment works well. It says the device met a regulatory standard for its stated purpose - nothing more.
Some people describe looking thinner or more hollow after energy-based tightening, and this comes up often enough to deserve a straight answer rather than a denial.
Subcutaneous fat atrophy is listed among the rare documented adverse events of focused ultrasound, alongside transient injury to the motor nerves of the face. The same rare event is documented for monopolar radiofrequency tightening. So the phenomenon is recognised across heat-based tightening, not invented online.
Here is the limit of what can be said. There is no published figure for how often facial fat loss occurs after focused ultrasound. No incidence rate, no case series quantifying it, no data on whether it recovers. Anyone who gives you a percentage is making it up.
For context from a neighbouring device class: in an analysis of FDA postmarket reports about radiofrequency microneedling covering 2013 to 2025, fat loss made up 26 of 224 reported events. That is a different technology, and the number is a proportion of the reports that were filed, with no denominator - nobody knows how many treatments those reports came from, so it cannot be turned into a chance that something happens to you. It is evidence that the concern is real and discussed, not a risk figure.
The fair summary: unwanted volume loss after tightening treatments is a documented, unquantified risk - and it is the opposite of a selling point.
Working out which one you have is the whole question, and it is worth asking your provider directly. Loose skin and a fat pocket look similar in a mirror and respond to completely different tools.
These are the treatments whose approved wording actually names fat. They are listed as different tools for a different problem, not as recommendations.
Because losing fat can make loose skin more obvious, these and a tightening treatment are sometimes considered together rather than as alternatives. That is a conversation to have with a provider who will examine you.
Ultherapy does not break the skin, which removes a whole category of risk. If your plan involves anything that does break the skin - microneedling, radiofrequency microneedling, or an injectable treatment - tell the clinic at booking if you get cold sores. Antiviral medicine is started in advance, so it has to be prescribed before the appointment, not after a blister appears.